U.S. CTC Registry Shows High Survival Using CytoSorb In Critically Ill COVID-19 Patients On ECMO

CytoSorbents Corporation (CTSO) on Wednesday announced topline CTC (CytoSorb Therapy in COVID-19) Registry results showing high survival rate in critically ill COVID-19 patients on Extracorporeal Membrane Oxygenation (ECMO) treated with CytoSorb.

CytoSorb, commercialized by CytoSorbents, is a single-use device, designed to reduce inflammatory mediators in the blood.

The results were presented on Tuesday at the 40th International Symposium on Intensive Care and Emergency Medicine (ISICEM 2021) in Brussels, Belgium.

CytoSorbents said the 90-day ICU mortality was 27% with ECMO + CytoSorb in CTC Registry, which is well below 50% reported in the North American cohort of the ELSO (Extracorporeal Life Support Organization) registry, the company said.

Furthermore, no adverse events were reported, and CytoSorb was well-tolerated and easily integrated in the ECMO circuit.

CytoSorb had received FDA Emergency Use Authorization in April 2020 for use in critically ill COVID-19 patients, 18 years of age or older.

"We are encouraged by the topline CTC Registry results presented at ISICEM, particularly the favorable safety profile of CytoSorb when used as an adjunct therapy in the highest risk COVID-19 patients requiring life support with ECMO and by the high survival rates observed that compare favorably to the global experience with ECMO alone captured in real time by the ELSO COVID-19 Registry," said Efthymios N. Deliargyris, Chief Medical Officer of CytoSorbents.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. air travel industry is going through its worst crisis since the troubled travel time during the peek pandemic struggles, with thousands of flights across the country being cancelled or getting delayed. The aviation crisis, as millions are preparing to travel during the upcoming July 4th holiday weekend, is mainly attributed to the staffing issues at airlines, ... The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for Siluriformes products imported by Carlstadt, New Jersey- based Grand BK Corp. The products were imported from Korea, a country ineligible to export Siluriformes products to the United States. Blount Fine Foods is recalling a limited amount of Panera at Home Southwest Corn Chowder citing undeclared wheat allergen, the U.S. Food and Drug Administration said. The recall involves a single lot of 16 oz. product with UPC Code 077958690812, lot number 042122-2K and "Use By" date of 6/30/22 that comes around 2,569 cases in total. The recall is limited to 1 SKU of 16 oz.
Follow RTT